Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vycor Medical (VYCO) EBT (2016 - 2025)

Vycor Medical has reported EBT over the past 16 years, most recently at -$17749.0 for Q4 2025.

  • Quarterly EBT fell 196.29% to -$17749.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$25560.0 through Dec 2025, up 68.77% year-over-year, with the annual reading at -$25560.0 for FY2025, 68.77% up from the prior year.
  • EBT was -$17749.0 for Q4 2025 at Vycor Medical, down from $4990.0 in the prior quarter.
  • Over five years, EBT peaked at $261471.0 in Q4 2022 and troughed at -$230747.0 in Q1 2021.
  • The 5-year median for EBT is -$24128.0 (2024), against an average of -$27757.8.
  • Year-over-year, EBT tumbled 10463.31% in 2022 and then surged 357.41% in 2025.
  • A 5-year view of EBT shows it stood at -$176391.0 in 2021, then soared by 248.23% to $261471.0 in 2022, then tumbled by 120.55% to -$53743.0 in 2023, then soared by 134.3% to $18432.0 in 2024, then plummeted by 196.29% to -$17749.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's EBT are -$17749.0 (Q4 2025), $4990.0 (Q3 2025), and $25713.0 (Q2 2025).